Form 4: BioCardia CEO Acquires Shares

BioCardia, Inc. reports that its President and CEO, Peter Altman, acquired 110,625 shares of common stock on June 29, 2026, as part of his compensation.

Summary

• Peter Altman, President and CEO of BioCardia, Inc., acquired 110,625 shares of common stock on June 29, 2026.
• These shares were acquired as restricted stock units (RSUs) awarded as compensation in lieu of cash.
• The RSUs fully vested on June 29, 2026.
• Following this transaction, Altman beneficially owns 411,191 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a standard insider transaction related to executive compensation and does not provide new financial performance data or strategic updates.

Positives

• CEO acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 110,625 shares as compensation indicates a commitment from leadership.
• The vesting of RSUs on June 29, 2026, shows a milestone in executive compensation.

Future Outlook

No specific future outlook or guidance is provided in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from BioCardia, are standard disclosures for insider transactions. While they can sometimes signal management confidence, they are primarily for transparency regarding ownership changes by directors and officers.

Stakeholder Impact

• Shareholders: Increased transparency regarding the CEO's beneficial ownership of company stock.

Key Dates

Keywords

BioCardia, BCDA, Form 4, SEC Filing, Insider Trading, Executive Compensation, Restricted Stock Units, Peter Altman